alendronate and montelukast

alendronate has been researched along with montelukast in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y1
Bailey, B; Carrière, B; Chabot, G; Lebel, D1
Ayanoğlu-Dülger, G; Cetinel, S; Cikler, E; Kapucu, C; Sener, G1

Reviews

1 review(s) available for alendronate and montelukast

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for alendronate and montelukast

ArticleYear
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone

2016
Dispensing error leading to alendronate ingestion.
    The Annals of pharmacotherapy, 2003, Volume: 37, Issue:1

    Topics: Acetates; Alendronate; Asthma; Calcium Channel Blockers; Child; Cyclopropanes; Drug Packaging; Esophagitis; Humans; Leukotriene Antagonists; Male; Medication Errors; Quinolines; Sulfides

2003
Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa.
    Prostaglandins, leukotrienes, and essential fatty acids, 2005, Volume: 72, Issue:1

    Topics: Acetates; Alendronate; Animals; Cyclopropanes; Female; Gastric Acidity Determination; Gastric Mucosa; Glutathione; Hydrogen-Ion Concentration; Kidney; Leukotriene Antagonists; Liver; Male; Malondialdehyde; Peroxidase; Quinolines; Rats; Rats, Wistar; Stomach Ulcer; Sulfides

2005